SEC Form 4 · accession 0000899243-17-023037
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Sender
Officer — See Remarks
Period of report
Sep 27, 2017
Accepted (ET)
Sep 29, 2017 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 27, 2017 | F | 847 | $54.66 | D | 10,857 | D | |
| Common Stock | Sep 27, 2017 | F | 847 | $54.66 | D | 10,010 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Chief Clinical Operations Officer